Recombinant Frog virus 3 Uncharacterized protein 093L (FV3-093L)

Shipped with Ice Packs
In Stock

Description

Identification and Genomic Context

FV3-093L corresponds to Open Reading Frame (ORF) 93L in the Frog Virus 3 genome (GenBank accession: AY548484) . The FV3 genome spans ~105 kbp and encodes 98 putative ORFs, with ORF93L located in a region associated with late-stage viral replication .

Table 1: Key Genomic Features of FV3-093L

FeatureDetail
Genomic PositionORF93L (coordinates vary by isolate)
Temporal ClassLate (L) gene
HomologyNo significant homology to known proteins
Expression PatternUpregulated during late infection phase

Temporal Classification and Expression Dynamics

Microarray analyses of FV3-infected cells classified ORF93L as a late (L) gene, showing progressive upregulation post-infection :

Table 2: Expression Levels of FV3-093L Over Time

Time Post-InfectionFold Change (vs. Mock-Infected Cells)
2 hours0.864
4 hours13.8
9 hours86.97

Late genes like ORF93L are typically involved in structural or assembly processes, such as virion packaging, though direct experimental evidence for FV3-093L’s role is lacking .

Comparative Analysis with Other FV3 Proteins

FV3-093L contrasts with early-expressed regulatory proteins like ORF97R (MCL-1 homolog) and ORF64R (vCARD), which directly interact with host apoptosis pathways .

Table 3: Temporal and Functional Comparison

ProteinTemporal ClassKnown/Predicted Function
FV3-093LLate (L)Unknown; potential structural role
ORF97RImmediate EarlyBcl-2 homolog; ER localization
ORF64R (vCARD)Immediate EarlyCaspase inhibition; virulence

Research Challenges and Future Directions

  • Functional Characterization: Structural studies (e.g., cryo-EM) or yeast-two-hybrid screens could identify binding partners.

  • Evolutionary Context: Recombination hotspots in the FV3 genome near ORF93L suggest potential adaptive evolution, but recombination events involving this ORF are undocumented .

  • In Vivo Models: Tissue-specific expression patterns in amphibians (e.g., kidney, spleen) warrant validation using spatial transcriptomics .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during ordering for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, serving as a guideline for your use.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
FV3-093LUncharacterized protein 093L
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-55
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Frog virus 3 (isolate Goorha) (FV-3)
Target Names
FV3-093L
Target Protein Sequence
MDKPTVETSA APVETLVLTE PPAETQAEDS VSSVLAGLTA AIETVDRLRT AFGAE
Uniprot No.

Q&A

What is the current classification status of FV3-093L?

FV3-093L is classified as an uncharacterized protein encoded by Frog Virus 3, the type species of the genus Ranavirus within the Iridoviridae family. The designation "uncharacterized protein" indicates that while the gene has been identified through genomic sequencing, its function remains largely unknown . FV3's genome contains approximately 100 putative open reading frames (ORFs), many of which, like 093L, have not been functionally characterized in viral pathogenesis . Current annotation of such proteins typically relies on sequence prediction tools rather than experimental validation.

What genomic and structural information is available for FV3-093L?

While specific information about FV3-093L is limited in the literature, we can draw some parallels with other iridoviruses. In Invertebrate Iridescent Virus Type 3 (IIV-3), a related iridovirus, ORF designations include an IIV3-093L . Iridoviridae genomes typically show little colinearity between different viral species, so direct comparisons require caution . Based on patterns observed in other iridoviruses, FV3-093L likely resides in a specific genomic region that may or may not be adjacent to functionally related genes.

For researchers beginning work with this protein, preliminary structural analysis should include:

Analysis ApproachExpected OutputUtility in Research
BLAST homology searchPotential functional homologsInitial functional predictions
Domain predictionConserved protein domainsInsight into biochemical function
Secondary structure analysisAlpha-helices, beta-sheetsStructural characterization
Signal peptide predictionPotential cellular localizationInsight into protein trafficking

How does FV3-093L expression vary across infection stages?

Recent transcriptomic studies have classified FV3 genes into temporal expression classes: immediate early, delayed early, and late viral transcripts based on their sequential expression during infection . While specific data on FV3-093L temporal expression is not explicitly mentioned in the available literature, researchers should determine whether it belongs to immediate early (IE), delayed early (DE), or late (L) viral gene classes, as this classification provides valuable insights into potential function. Temporal expression patterns can be determined using RNA-Seq analysis of infected cells at different time points post-infection .

What expression systems are optimal for producing recombinant FV3-093L?

For researchers working to produce recombinant FV3-093L, several expression systems should be considered:

Bacterial expression systems (e.g., E. coli) offer simplicity and high yields but may not provide proper folding or post-translational modifications. For viral proteins like FV3-093L, eukaryotic expression systems often yield better results. Propagation of FV3 has been successfully demonstrated in Epithelioma Papulosum Cyprini (EPC) cells, suggesting that fish cell lines may support proper folding of ranaviral proteins . Alternatively, amphibian cell lines like Xela DS2 and Xela VS2 derived from Xenopus laevis have been shown to support FV3 replication and may serve as more native systems for expression .

The protocol for recombinant protein production should generally include:

  • Gene synthesis or amplification from viral genomic DNA

  • Cloning into an appropriate expression vector with affinity tag

  • Expression optimization (temperature, induction time, media composition)

  • Protein purification using affinity chromatography

  • Validation of protein identity using mass spectrometry

What approaches can identify potential interaction partners of FV3-093L?

To identify host and viral proteins that interact with FV3-093L, researchers should consider:

Yeast two-hybrid screening can identify binary protein-protein interactions but may produce false positives. Co-immunoprecipitation followed by mass spectrometry offers a more physiologically relevant approach to identify interaction partners in infected cells. For viral proteins potentially involved in immune evasion, pull-down assays using recombinant FV3-093L as bait against amphibian immune cell lysates may reveal interactions with host defense proteins.

Recent studies have identified several FV3 proteins that contain domains mimicking host interferon regulatory factors (IRFs) and interferon receptors, suggesting viral mechanisms for immune evasion . Similar analysis of FV3-093L's sequence may reveal whether it contains domains potentially involved in host immune interference.

How can researchers develop effective antibodies against FV3-093L?

Development of specific antibodies against FV3-093L is essential for many experimental applications. The recommended approach involves:

  • Expression and purification of recombinant FV3-093L protein fragments

  • Immunization of rabbits or mice with purified protein

  • Validation of antibody specificity using both recombinant protein and virus-infected cells

  • Purification of antibodies using affinity chromatography

For uncharacterized viral proteins, producing antibodies against multiple regions of the protein increases the likelihood of obtaining functional antibodies for various applications such as Western blot, immunofluorescence, and immunoprecipitation studies.

What gene knockout strategies are most effective for studying FV3-093L function?

For definitive functional characterization of FV3-093L, gene knockout or knockdown approaches are essential. Current studies with FV3 have utilized several effective strategies:

Antisense morpholino oligonucleotides (asMOs) have been successfully employed to knock down FV3 genes . These molecules bind to complementary mRNA sequences, preventing translation. Small interfering RNAs (siRNAs) provide an alternative approach for transient knockdown of viral gene expression .

For permanent gene knockout, homologous recombination techniques have been used with ranaviral genomes, replacing the target gene with a selectable marker . This approach would allow researchers to generate an FV3-Δ093L recombinant virus similar to the FV3-Δ64R strain that has been previously characterized . Comparison of wildtype and knockout virus replication in various tissues would provide insights into the role of FV3-093L in viral pathogenesis.

Knockout StrategyAdvantagesLimitationsApplicability to FV3-093L
Antisense morpholinosTransient knockdown, ease of deliveryIncomplete suppressionGood for initial characterization
siRNAEfficient knockdown, commercially availablePotential off-target effectsUseful for in vitro studies
CRISPR/Cas9Permanent knockout, high specificityComplex delivery to viral genomeChallenging but most definitive
Homologous recombinationGenerates stable viral mutantLabor intensiveProvides definitive functional data

How does FV3-093L expression vary across different amphibian host tissues?

Comprehensive transcriptomic studies have revealed that FV3 gene expression varies significantly across different host tissues. In Xenopus laevis infected with FV3, full-genome coverage of viral transcripts was observed in intestine, liver, spleen, lung, and especially kidney, while only partial transcript coverage was detected in thymus, skin, and muscle . For researchers investigating FV3-093L, tissue-specific expression analysis would be valuable for understanding its role in viral pathogenesis.

A recommended experimental approach would include:

  • Infection of adult Xenopus laevis with FV3

  • Collection of tissues at various time points post-infection

  • RNA isolation and RT-qPCR using FV3-093L-specific primers

  • Tissue-specific protein expression analysis using immunohistochemistry

Understanding the tissue tropism of FV3-093L expression may provide insights into its potential role in viral replication or immune evasion in specific host tissues.

What bioinformatic approaches can predict FV3-093L function?

For uncharacterized proteins like FV3-093L, computational approaches can provide initial functional hypotheses:

Phylogenetic analysis comparing FV3-093L to homologs in other ranaviruses and more distantly related iridoviruses can reveal evolutionary conservation patterns. Structural prediction using tools like AlphaFold2 can generate three-dimensional models that may suggest functional domains. Molecular dynamics simulations can explore potential binding interactions with candidate host or viral proteins.

Particular attention should be paid to domains potentially involved in immune evasion, as FV3 has been shown to encode proteins containing viral mimicking domains that interfere with host interferon signaling . If FV3-093L contains similar domains, it may participate in viral immune evasion strategies.

How might FV3-093L contribute to immune evasion in amphibian hosts?

Recent research has identified several viral-encoded proteins in FV3 that contain domains mimicking host interferon regulatory factors (IRFs) and interferon receptors, suggesting mechanisms for interfering with host immune responses . To investigate whether FV3-093L plays a role in immune evasion:

  • Examine FV3-093L sequence for domains similar to host immune components

  • Assess the impact of recombinant FV3-093L on amphibian interferon signaling pathways

  • Compare immune responses to wildtype FV3 versus FV3-Δ093L (if available)

  • Evaluate cytokine expression in response to FV3-093L in amphibian cells

Studies have shown that Xela DS2 and Xela VS2 cell lines derived from Xenopus laevis upregulate antiviral and proinflammatory cytokine transcripts in response to poly(I:C) but not to FV3 or UV-inactivated FV3 . These cell lines could serve as valuable models to investigate whether FV3-093L contributes to this viral suppression of host immune responses.

Can prior induction of antiviral responses protect against FV3-093L-mediated effects?

Research has demonstrated that pretreatment with poly(I:C), a synthetic analog of viral double-stranded RNA, limits FV3 replication and virus-induced cytopathic effects in amphibian cell lines . For researchers investigating FV3-093L, this raises important questions about whether pre-establishing antiviral states might specifically counteract functions of this protein.

An experimental approach could include:

  • Pretreatment of amphibian cells with poly(I:C) or other immune stimulants

  • Exposure to purified recombinant FV3-093L protein or transfection with FV3-093L expression vectors

  • Assessment of cellular responses, including cytopathic effects and antiviral gene expression

  • Comparison with results from whole virus infection studies

This approach could help determine whether FV3-093L functions are specifically inhibited by pre-established antiviral states, providing insights into its potential role in viral pathogenesis.

How can FV3-093L research inform conservation efforts for amphibian populations?

FV3 and related ranaviruses significantly contribute to catastrophic amphibian declines worldwide . Understanding the function of viral proteins like FV3-093L could inform conservation strategies through:

  • Development of molecular diagnostic tools targeting conserved viral genes

  • Identification of potential antiviral targets if FV3-093L proves essential for viral replication

  • Better understanding of viral persistence mechanisms in adult frogs, which may serve as reservoirs

If FV3-093L is confirmed to play a role in immune evasion, this knowledge could inform ecological studies examining why certain amphibian populations show differential susceptibility to ranavirus infections.

What potential does FV3-093L have as a target for antiviral development?

To evaluate FV3-093L as a potential antiviral target, researchers should:

  • Determine whether FV3-093L is essential for viral replication through knockout studies

  • Identify critical functional domains that could be targeted by small molecule inhibitors

  • Screen compound libraries for molecules that bind specifically to purified FV3-093L

  • Evaluate the effect of promising compounds on viral replication in cell culture systems

If FV3-093L proves to be involved in host immune evasion, as suggested for other viral proteins with IRF-mimicking domains , it could represent a particularly valuable target for therapeutic intervention, potentially restoring host immune recognition of the virus.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.